Polycystic Ovarian Syndrome Treatment Market: Global Industry Analysis and Forecast (2023-2029)

Polycystic Ovarian Syndrome Treatment Market was valued at US$ 5.60 Bn in 2022 and expected to grow at US$ 10.75 Bn in 2029. Polycystic Ovarian Syndrome Treatment Market size is expected to grow at a CAGR of 9.77 % through the forecast period.
Polycystic Ovarian Syndrome Treatment Market Overview:
Polycystic ovary syndrome (PCOS) is a condition in which the ovaries produce an abnormal number of androgens, male sex hormones that are usually present in women in small amounts. The name polycystic ovary syndrome describes the numerous small cysts (fluid-filled sacs) that form in the ovaries. However, some women with this disorder do not have cysts, while some women without the disorder do develop cysts. Many women with PCOS have insulin resistance. This means the body can't use insulin well. Insulin levels build up in the body and may cause higher androgen levels. Obesity can also increase insulin levels and make PCOS symptoms worse.To know about the Research Methodology:-Request Free Sample Report

Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Women with PCOS may have infrequent or prolonged menstrual periods or excess male hormone (androgen) levels. The ovaries may develop numerous small collections of fluid (follicles) and fail to regularly release eggs. If you have signs and symptoms of PCOS, they'll usually become apparent during your late teens or early 20s. PCOS is also associated with an increased risk of developing health problems in later life, such as type 2 diabetes and high cholesterol levels.

The report explores the Polycystic Ovarian Syndrome Treatment Market segments (Drug Type, Surgery Type, Distribution Channel and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2022. The report investigates the Polycystic Ovarian Syndrome Treatment Market drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Polycystic Ovarian Syndrome Treatment Market contemporary competitive scenario.

2022 is considered as a base year to forecast the market from 2023 to 2029. 2022’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years' trends are considered while forecasting the market through 2029. 2022 is a year of exception and analysis especially with the impact of lockdown by region.
Polycystic Ovarian Syndrome Treatment Market Dynamics:
The Polycystic Ovarian Syndrome Treatment Market (PCOS) dynamics are thoroughly studied and explained in the report, which helps reader to understand emerging market trends, drivers, restraints, opportunities, and challenges at global and regional level for the Polycystic Ovarian Syndrome Treatment Market (PCOS).

The most significant factor which is driving the growth for this market is the rising cases of polycystic ovarian syndrome (PCOS) across the world. The increasing Sedentary lifestyle and faulty dietary habits around the globe is driving the Polycystic Ovarian Syndrome Treatment Market (PCOS). The factors such as the rising regularity of diabetes and obesity among women, increasing hormonal disorders in women, socioeconomic factors, change in sedentary lifestyle, and growing consumption of unhealthy diet leads to the growth of the Polycystic Ovarian Syndrome Treatment Market.

Furthermore, the expanding healthcare sector, adoption of combination drugs, and rising patient adoption are also expected to boost the growth of the market. In addition to this, the rising awareness among the patients and doctors regarding the chronic diseases and hospital-acquired infections also increasing the market’s growth during the forecasted period. The focus of leading manufacturers on expanding their geographic presence increasing the demand for the Polycystic Ovarian Syndrome Treatment Market (PCOS).

The various side effects occur in the drugs for treating polycystic ovary syndrome. The various side effects which are associated with drugs includes cardiovascular risks, weight gain, abnormal glucose tolerance, increase insulin resistance and thromboembolic events are expected to restrain the market growth. The lack of approved therapeutics and lack of FDA drug approval is projected to challenge the polycystic ovarian syndrome (PCOS) treatment market in the forecast period of 2023-2029. The growth of the market will also get obstructed due to the lack of specific treatment for this disorder along with the unknown aetiology and pathophysiology of polycystic ovarian syndrome. The increasing side effects associated with generics will also lead to the restrain of the growth of the  Market. The lack of FDA approved drugs among many countries around the globe is the major restraint for the Market (PCOS).

Post COVID-19 Impact:

Healthcare industry was largely affected by the outbreak of COVID-19. As Polycystic Ovarian Syndrome Treatment Market have adverse effect, the polycystic ovarian syndrome (PCOS) treatment market does not stand back as pandemic various operations, supply chain disruptions, stifling business growth, suspensions of new developments had consequences for many surgical operations which includes laparoscopic ovarian drilling. The various operations, supply chain disruptions, stifling business growth, suspensions of new developments have adversely affected market negatively due to the regulations such as lockdown and social distancing which is imposed by the government during the outbreak of COVID-19 pandemic.

This leads to the suspension of non-essential treatment surgeries or procedures. According to Experts at the University of Birmingham, patients who have contracted coronavirus and undertake surgery are at an increased risk of postoperative mortality, and that all non-emergent surgeries should be avoided. Therefore, the guidelines are given to the surgeons to maintain normal surgical practices and said to follow to for the safe and effective care to their patients throughout the COVID-19 pandemic.

After the cases of COVID-19 patients started decreasing, the restrictions which are applied by the government are likely to relax. As the market leads to the slight increment after the post COVID-19 situation, the normal surgical practices can occur according to few guidelines that surgeons must implement for the effective care to their patients throughout the treatment. According to the new standards the healthcare practitioners have been able to restart their surgery practices. Hence, it is proposed that laparoscopic ovarian drilling treatments will start their usual growth after the COVID-19 pandemic.
Segment Analysis:
Based on Drug Type, The insulin-sensitizing agents segment dominated the market with the highest CAGR of xx% during the forecast period. The wide adoption of the drug for the treatment of insulin resistance which is used for the prevention of diabetes and which is one of the major cause of PCOS market. This leads to the growth of the insulin-sensitizing agents segment. Based on the diagnosis, the market is further classified into ultrasound, pelvic exam, and blood test.The oral contraceptive pills market is also predicted to rise at a fast pace. The most commonly used oral contraceptive pills are Drospirenone, Medroxyprogesterone Acetate, & Ethinyl Estradiol. These OCPs such as Polycystic ovary syndrome complications such as prolonged or missing menstrual cycles, extreme menstrual cramps, Premenstrual syndrome (PMS), and acne are used for curing the PCOS. Therefore, the OCP market is increasing day-by-day of Polycystic Ovarian Syndrome Treatment Market.

Based on Distribution Channel, According to distribution channel, the polycystic ovarian syndrome treatment market is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. The segment online providers are expected to growth with the highest share market during the forecast period.Due to rise in preference for online purchasing of drugs over the traditional methods this leads to the increasing demand for the online providers segment. The Polycystic Ovarian Syndrome Treatment Market is boosting up in the online providers segment because of the increase awareness of online providers and rise in number of internet users.
Polycystic Ovarian Syndrome Treatment Market Regional Insights:
The North America region is expected to witness significant growth at a CAGR of xx% through the forecast period. North America dominates the polycystic ovarian syndrome (PCOS) treatment market because of the high awareness and the availability of advanced healthcare facilities within the region. Due to the rising prevalence of PCOS disorder and the large presence of the obese female population the market is boosting up in the North America region.

In this disease mostly the females are getting affected. This increasing prevalence creating the strong demands for an effective treatment for PCOS. In addition, high reimbursement policies which are passed by the government in the healthcare sector and awareness amongst the population regarding the early diagnosis of the disorder, and adoption of minimal invasive surgeries (MIS) are significantly contributing towards the market growth in the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2029 due to the government initiatives to raise awareness about the symptoms and diagnosis of PCOS and available treatment, which are increasing the number of women diagnosed with this syndrome within the region. improvement in healthcare infrastructure, rise in number of target population, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare leads to the increasing demand for the Market. In addition, to capture high growth opportunities in the market, high population base, and high disposable incomes factors such as surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries are expected to boost up the growth of the polycystic ovarian syndrome treatment market in Asia-Pacific region.

The objective of the report is to present a comprehensive analysis of the Polycystic Ovarian Syndrome Treatment Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Polycystic Ovarian Syndrome Treatment Market dynamic, structure by analyzing the market segments and projecting the Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Polycystic Ovarian Syndrome Treatment Market make the report investor’s guide.
Polycystic Ovarian Syndrome Treatment Market Scope: Inquire before buying



Global Polycystic Ovarian Syndrome Treatment Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US$ 5.60 Bn.


Forecast Period 2023 to 2029 CAGR:
9.77%
Market Size in 2029:
US$ 10.75 Bn.


 Segments Covered:
by Drug Type
Oral contraceptives drug
Antiandrogen drug
Insulin-sensitizing agents
Antidepressants drug
Anti-obesity drug


by Surgery Type
wedge resection
laparoscopic drilling


by Distribution Channels
Hospital Pharmacies
Drug Stores & Retail Pharmacies
online providers



Polycystic Ovarian Syndrome Treatment Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key Players:
1. Sanofi
2. Novartis AG
3. Teva Pharmaceutical Industries Limited
4. Addex Therapeutics Ltd.
5. BIOCAD
6. Merck KGaA
7. AstraZeneca plc.
8. Bristol Myers Squibb Co.
9. Ferring Pharmaceuticals, Inc.
10.Crinetics Pharmaceuticals, Inc.
11.Allergan plc.
12.Bayer AG
13.Johnson and Johnson
14.Mylan N.V.
15.Pfizer Inc.
16.BIOCAD
17.Abbott
Frequently Asked Questions:
1] What segments are covered in the Market report?
Ans. The segments covered in the Market report are based on Drug Type, Surgery Type and Distribution Channel.

2] Which region is expected to hold the highest share in the Global Polycystic Ovarian Syndrome Treatment Market?
Ans. North America region is expected to hold the highest share in the  Market.

3] What is the market size of the Market by 2029?
Ans. The market size of the Market by 2029 is expected to reach US$ 10.75 Bn.

4] What is the forecast period for the Market?
Ans. The forecast period for the Market is 2023-2029.

5] What was the market size of the Market in 2022?
Ans. The market size of the Market in 2022 was valued at US$ 5.60 Bn.